Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Contagiend Solutions
AddedFeb 17, 2024
UpdatedJun 18, 2026
Contagiend Solutions

Contagiend Solutions

NYC-based Contagiend Solutions offers innovative products to protect patients from infections due to unsafe medical practices.

HQ
New York City, NY, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Contagiend Solutions, founded in New York City, aims to minimize the spread of contagious diseases in healthcare settings by eliminating human error through innovative products. The company focuses on protecting patients from viral, bacterial, and fungal infections resulting from unsafe medical injection practices. Their offerings are tailored for hospitals and clinics, addressing critical issues like syringe reuse and medication vial misuse to prevent outbreaks of HIV, hepatitis B, and hepatitis C.

Notable figures associated with Contagiend Solutions include Dr. Manavjeet Sidhu, M.D./M.B.A., who serves as CEO. The organization has made significant strides in enhancing patient safety and has been recognized for its impactful solutions in infection control. By addressing a crucial gap in medical safety protocols, Contagiend Solutions has contributed to reducing the risk of healthcare-associated infections, thereby improving overall public health outcomes.

Contagiend Solutions - Similar Companies

Equashield logo

Equashield

equashield.com

Prevacept Infection Control logo

Prevacept Infection Control

KleenGel logo

KleenGel

Sonix Medical Devices logo

Sonix Medical Devices

Contego Medical logo

Contego Medical

contegomedical.com

Gant Medical logo

Gant Medical

gantmed.com

Sanus Solutions logo

Sanus Solutions

sanussolutions.com

BioVigil logo

BioVigil

Radux Devices logo

Radux Devices

raduxdevices.com

Novogiene logo

Novogiene

True Concepts Medical Technologies logo

True Concepts Medical Technologies

AseptiScope logo

AseptiScope

aseptiscope.com

Solution Medical logo

Solution Medical

Midas Healthcare Solutions logo

Midas Healthcare Solutions

midashs.com

NitriCap Medical logo

NitriCap Medical

Contagiend Solutions - Quick Facts

Who are Contagiend Solutions' competitors?

Companies similar to Contagiend Solutions include Equashield, Prevacept Infection Control, KleenGel and Sonix Medical Devices.

When was Contagiend Solutions founded?

Contagiend Solutions was founded in 2016.

Where is Contagiend Solutions' headquarters located?

Contagiend Solutions' headquarters is located in New York City, NY, US.

When was Contagiend Solutions' last funding round?

Contagiend Solutions' most recent funding round was for $75k (USD) in June 2016.

How much has Contagiend Solutions raised to-date?

As of Jun 1, 2016, Contagiend Solutions has raised a total of $75k (USD).

How many employees does Contagiend Solutions have?

Contagiend Solutions has 5 employees as of Feb 4, 2024.

Contagiend Solutions - Classification

Industry
  • Hardware
Technology
  • IoT
  • RFID
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities